Skip to content

Boosting recovery through excitation of arousal and awareness in comatose patients: Dose finding study (BREA2KTHROUGH DOSEFINDER)

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-503617-30-02
Enrollment
384
Registered
2024-05-28
Start date
2025-02-26
Completion date
Unknown
Last updated
2025-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coma and other disorders of consciousness due to acute traumatic and non-traumatic brain injury

Brief summary

Time to awakening within 30 days (overall safety)

Detailed description

Pupillary function (pupillometry, including spontaneous pupillary function and during a mental arithmetic paradigm), Neurovascular coupling (NIRS-EEG, including spontaneous cortical activity and activation during a tongue motor imagery paradigm) at days 1 and 7, Clinical outcome at day 90 (GOS-E), Days alive outside the ICU, Serious adverse reactions (SARs), somatic and neuropsychiatric, Serious adverse events, somatic and neuropsychiatric

Interventions

Sponsors

Rigshospitalet
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Design outcomes

Primary

MeasureTime frame
Time to awakening within 30 days (overall safety)

Secondary

MeasureTime frame
Pupillary function (pupillometry, including spontaneous pupillary function and during a mental arithmetic paradigm), Neurovascular coupling (NIRS-EEG, including spontaneous cortical activity and activation during a tongue motor imagery paradigm) at days 1 and 7, Clinical outcome at day 90 (GOS-E), Days alive outside the ICU, Serious adverse reactions (SARs), somatic and neuropsychiatric, Serious adverse events, somatic and neuropsychiatric

Countries

Denmark

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026